Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney" [Matrix Biology 68-69 (2018) 293-317].

Matrix biology : journal of the International Society for Matrix Biology·2026
Same author

Restoring Balance in Autoimmune Hepatitis.

Cellular and molecular gastroenterology and hepatology·2026
Same author

Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 Diabetes.

Molecular metabolism·2025
Same author

The XCL1/XCR1 axis is upregulated in type 1 diabetes and aggravates its pathogenesis.

JCI insight·2025
Same author

Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.

EBioMedicine·2024
Same author

Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.

Journal of autoimmunity·2024

Related Experiment Video

Updated: Jul 15, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Animal models for autoimmune hepatitis.

Urs Christen1, Martin Holdener, Edith Hintermann

  • 1Johann Wolfgang Goethe University, Frankfurt am Main, Germany. christen@med.uni-frankfurt.de

Autoimmunity Reviews
|April 7, 2007
PubMed
Summary

This review focuses on autoimmune hepatitis (AIH), a severe liver disease. Current animal models often fail to replicate persistent hepatic damage seen in human AIH.

Area of Science:

  • Hepatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC) are autoimmune liver diseases.
  • Diagnosis can be complicated by overlapping clinical, histological, and immunological features, particularly autoantibody formation.
  • AIH is characterized by interface hepatitis, plasma cell infiltration, hypergammaglobulinemia, and autoantibodies.

Purpose of the Study:

  • To review the current state of animal models for autoimmune hepatitis (AIH).
  • To highlight the challenges in developing reliable models that mimic human AIH pathology.

Main Methods:

  • Review of existing literature on AIH and its animal models.
  • Focus on type 2 AIH, characterized by LKM-1 autoantibodies targeting cytochrome P450 isoform 2D6 (CYP2D6).

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Experiment Videos

Last Updated: Jul 15, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Main Results:

  • Animal models have historically struggled to replicate the persistent hepatic destruction characteristic of human AIH.
  • Many existing models induce only transient liver damage.
  • Disease induction in current models is often complex.

Conclusions:

  • Developing effective animal models for AIH remains a significant challenge.
  • Further research is needed to create models that accurately reflect the chronic nature of human autoimmune hepatitis.